Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases

We studied the lipolysis of Gelucire® 44/14 by porcine pancreatic extracts, human pancreatic juice and several purified digestive lipases

Sylvie Fernandez


Scholarcy highlights

  • Gelucire® 44/14 is a semi-solid self-emulsifying excipient used for the oral delivery of poorly water-soluble drugs
  • Human pancreatic lipase, the main lipase involved in the digestion of triacylglycerols, did not show any significant activity on Gelucire® 44/14 or on either of its individual compounds, C8-C18 acylglycerols and PEG-32 esters
  • We compared the lipolysis of Gelucire® 44/14 with that of Labrasol®, another self-emulsifying excipient, which is liquid at room temperature
  • Human pancreatic juice showed similar rates of activity on both Gelucire® 44/14 and Labrasol®. This finding means that these excipients are hydrolyzed in vivo during pancreatic digestion, mainly by Carboxyl ester hydrolase in the case of Gelucire® 44/14 and by both human pancreatic lipase-related protein 2 and CEH in that of Labrasol®, whereas HPL showed very low activities on each of these two excipients
  • This is the first time the effects of PEG and acyl chain length on the lipolytic activity of digestive lipases on PEG esters have been investigated

Need more features? Save interactive summary cards to your Scholarcy Library.